MORGAN JONES: Open Payments
NPI 1659959856 · LAWRENCEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,158 in 140 payments from 23 companies in 2025. Trend: 2023 $3,440 · 2024 $2,912 · 2025 $2,158
Food & beverage: $2,158
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 25 | $335 |
| AstraZeneca Pharmaceuticals LP | 15 | $278 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $253 |
| ABBVIE INC. | 25 | $210 |
| Bausch Health US, LLC | 9 | $206 |
| Tris Pharma Inc | 9 | $154 |
| Noven Therapeutics, LLC | 4 | $87 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $82 |
| PFIZER INC. | 4 | $77 |
| Astellas Pharma US Inc | 3 | $62 |
Products named: CAPLYTA, APLENZIN, Wegovy, AIRSUPRA, Dyanavel XR, Ozempic, UBRELVY, FARXIGA.
Industry payments across GA — which companies pay providers there.
